ArticleEuropean journal of case reports in internal medicine2018
Non-Uremic Calciphylaxis: A Rare Diagnosis with Limited Therapeutic Strategies.
Article in European journal of case reports in internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 24 citations in OpenAlex.
- Postparathyroidectomy calciphylaxis in a patient with primary hyperparathyroidism: a rare complication.JCEM case reports · 2026Article
- Surgical Approach in the Treatment of Calciphylaxis: A Case Report.Healthcare (Basel, Switzerland) · 2025Article
- Non-uremic calciphylaxis: A dermatologic complication in both MASH and alcohol-associated cirrhosis.Clinical nephrology. Case studies · 2025Article
- Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.Renal failure · 2024Article
- Non-chronic kidney disease-induced calciphylaxis: a rare case report.Journal of surgical case reports · 2024Article
- Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib-a case report.Journal of gastrointestinal oncology · 2024Article
- Article
- Surgical treatment of nonuremic calciphylaxis: a case report and review of literature.Case reports in plastic surgery & hand surgery · 2023Article
- Article
- Article
- Early onset calciphylaxis following acute kidney injury secondary to anti-glomerular basement membrane antibody disease.BMJ case reports · 2021Article
- A Case Report of Futibatinib-Induced Calciphylaxis.Kansas journal of medicineArticle
- Calciphylaxis in a Patient With Lupus Nephritis and Acute Kidney Injury: A Rare Case Report and Literature Review.Journal of investigative medicine high impact case reportsReview
- A Case Report of Non-Uremic Calciphylaxis Refractory to Treatment Requiring Multidisciplinary Care.Case reports in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calciphylaxis is a rare condition characterized by the emergence of non-healing skin ulcers secondary to arterial calcification and thrombosis, typically diagnosed in patients with end-stage kidney disease (ESKD). When it develops in patients without ESKD, it is called non-uremic calciphylaxis (NUC). The latter is an even rarer diagnosis with an uncertain pathophysiology and a high mortality rate (52%), mainly due to sepsis (50%). Cutaneous biopsy is diagnostic. Therapeutic measures recommended for NUC are limited to wound debridement, analgesia, and control of infection and risk factors. Other therapeutic options exist but with a low level of evidence. We present the case of a 78-year-old woman with NUC in her lower limbs who died of sepsis. NUC is a therapeutic challenge lacking efficient strategies. LEARNING POINTS: Calciphylaxis in the absence of end-stage kidney disease is called non-uremic calciphylaxis (NUC).This disease is a diagnostic and therapeutic challenge.As therapeutic strategies for NUC mainly derive from those for uremic calciphylaxis, more efficient therapeutic measures and evidence-based recommendations are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.